| P/E (FY) | — | Sales (TTM) | $0 |
| Earnings (TTM) | -$40.2M | ROE | −28.23% |
| Net Margin | — | ROIC | −360.73% |
| Debt / Equity | — | TD / EBITDA | — |
| EPS Growth 3Y | — | Sales Growth 3Y | — |
| Market Cap | $69.2M | Trading Days | 2836 |
| 52W High | 3.61 |
| 52W Low | 2.09 |
| % Off High | −37.12% |
| YTD | −5.02% | 1Y | −19.50% |
| 3Y | −55.23% | 5Y | −86.04% |
| 10Y | −81.25% | Since incept. (ann.) | −17.55% |
| Ann. Volatility (1Y) | 47.48% | Ann. Volatility (3Y) | 66.93% |
| Sharpe (1Y) | −0.23 | Sharpe (3Y) | −0.05 |
| Max Drawdown (1Y) | −39.43% | Max Drawdown (3Y) | −78.56% |
| Beta (3Y, vs SPY) | 0.96 |
| Ticker | Name | Mkt cap | P/E |
|---|---|---|---|
| IBIO | iBio, Inc. | $69.1M | — |
| TLPH | TALPHERA, INC. | $67.5M | — |
| RNTX | Rein Therapeutics, Inc. | $66.9M | — |
| OSTX | OS Therapies Inc | $66.8M | — |
| PLRX | PLIANT THERAPEUTICS, INC. | $66.3M | — |
| ACRV | Acrivon Therapeutics, Inc. | $65.9M | — |
| MNOV | MEDICINOVA INC | $65.5M | — |
| CYPH | CYPHERPUNK TECHNOLOGIES INC. | $65.4M | 8.8 |
| GANX | Gain Therapeutics, Inc. | $73.8M | — |
| CLNN | Clene Inc. | $63.8M | — |
| MAIA | MAIA Biotechnology, Inc. | $75.4M | — |
| HYFT | MindWalk Holdings Corp. | $63.5M | — |
